Frank A.G.M. Verwiel, M.D., President and Chief Executive Officer of Axcan Pharma, joined the Company in 2005 with more than 20 years of experience in the pharmaceutical industry.
Formerly with Merck & Co. Inc. (Merck) as vice president, hypertension, Worldwide Human Health Marketing, he concurrently served as a member of Merck’s Worldwide Hypertension Business Strategy team. Before Merck, from 1988 to 1996, Dr. Verwiel worked with Servier in Europe in various executive positions such as area director of Central European operations, which included Germany, Austria, Switzerland, the Netherlands, Belgium, and Luxembourg.
Dr. Verwiel holds Doctorate of Medicine and Master of Medicine degrees from Erasmus University in Rotterdam, the Netherlands. He also attended INSEAD in Fontainebleau, France, where he obtained a Master of Business Administration degree. Dr. Verwiel is fluent in Dutch, English, French, and German.